Article Text
Statistics from Altmetric.com
Regulation of stem cell research in Europe should not take place without public and scholarly input
The European Union (EU) has, at present, no jurisdiction over research carried out in the member states, or concerning the “ethics” of member states. This does not, however, mean that decisions made by the European institutions cannot influence such matters greatly.
There has recently been a lot of focus on the decision not to fund embryonic stem cell research during the first year of the 6th framework programme (mainly due to opposition to funding from the German government), but behind the scenes a much more important and wide ranging set of regulations are being prepared.
The European Commission has prepared a draft directive on setting standards of quality and safety for the donation, procurement, testing, processing, storage, and distribution of human tissues and cells.1 The purpose of this directive was originally to “ensure the quality and safety of human tissues and cells for clinical use” in the EU. This is clearly a laudable objective, fully in line with the EU’s jurisdiction in consumer protection and public health.
During the intricate processes of political …
Read the full text or download the PDF:
Other content recommended for you
- NIH Stem Cell Task Force Examines Barriers to Embryonic Stem Cell Research, and Other Stem Cell Research-related News
- Is a consensus possible on stem cell research? Moral and political obstacles
- Human embryonic stem cells and respect for life
- Embryo as epiphenomenon: some cultural, social and economic forces driving the stem cell debate
- Embryonic stem cells: the disagreement debate and embryonic stem cell research in Israel
- Stem cell stories: from bedside to bench
- Regenerative medicine: stem cells and the science of monstrosity
- Stem cells, embryos, and the environment: a context for both science and ethics
- The stem cell debate continues: the buying and selling of eggs for research
- Research Ethics, Science Policy, and Four Contexts for the Stem Cell Debate